Call-On-Doc

1. 3. The care-only tab additionally names branded and oral options, each with an advertised $75 care charge; this is not their medication price. No private eligibility, contact or payment form was entered. https://www.callondoc.com/en/weightloss
2. 4. Current public tabs show full-strength compounded tirzepatide at $375 and microdosing at $285. The expanded FAQ calls these monthly programs and says home-delivery medication ships each month, including provider management and dose adjustments. The card prices do not themselves establish the exact first invoice or recurring payment timing, so no payable monthly bill is asserted. The actual drug preparation and device remain unspecified. https://www.callondoc.com/en/weightloss
3. 5. Wegovy Injection appears in the current Care-Only (Pharmacy Pick-Up) catalog at an advertised $75 care charge. The patient separately buys the prescription at their chosen pharmacy; no drug price, first invoice or billing interval is established. This is a prescribing pathway, subject to clinical eligibility. https://www.callondoc.com/en/weightloss
4. 6. Ozempic appears in the current Care-Only (Pharmacy Pick-Up) catalog at an advertised $75 care charge. The patient separately buys the prescription at their chosen pharmacy; no drug price, first invoice or billing interval is established. This is a prescribing pathway, subject to clinical eligibility. https://www.callondoc.com/en/weightloss
5. 7. The current care-only card does not identify route or device. No injectable or oral form is inferred solely from the brand name, and it is not merged with the explicitly named Wegovy Injection card.
6. 8. Zepbound and Mounjaro appears in the current Care-Only (Pharmacy Pick-Up) catalog at an advertised $75 care charge. The patient separately buys the prescription at their chosen pharmacy; no drug price, first invoice or billing interval is established. This is a prescribing pathway, subject to clinical eligibility. https://www.callondoc.com/en/weightloss
7. 9. Current manufacturer primary labels identify both Zepbound and Mounjaro as tirzepatide injection. Device is not established by the prescribing service. https://pi.lilly.com/us/zepbound-uspi.pdf https://pi.lilly.com/us/mounjaro-uspi.pdf
8. 10. Saxenda appears in the current Care-Only (Pharmacy Pick-Up) catalog at an advertised $75 care charge. The patient separately buys the prescription at their chosen pharmacy; no drug price, first invoice or billing interval is established. This is a prescribing pathway, subject to clinical eligibility. https://www.callondoc.com/en/weightloss
9. 11. Current manufacturer primary information identifies Saxenda as liraglutide administered subcutaneously. No provider-specific device is inferred. https://www.novo-pi.com/saxenda.pdf
10. 12. Foundayo appears in the current Care-Only (Pharmacy Pick-Up) catalog at an advertised $75 care charge. The patient separately buys the prescription at their chosen pharmacy; no drug price, first invoice or billing interval is established. This is a prescribing pathway, subject to clinical eligibility. https://www.callondoc.com/en/weightloss
11. 13. The FDA primary approval bulletin and label identify Foundayo as orforglipron oral tablets; this mapping does not establish the patient’s dose or drug cost. https://content.govdelivery.com/accounts/USFDA/bulletins/4110b78 https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934s003lbl.pdf
12. 14. Oral Semaglutide appears in the current Care-Only (Pharmacy Pick-Up) catalog at an advertised $75 care charge. The patient separately buys the prescription at their chosen pharmacy; no drug price, first invoice or billing interval is established. This is a prescribing pathway, subject to clinical eligibility. https://www.callondoc.com/en/weightloss
13. 15. The current generic oral semaglutide card does not identify a brand, tablet, capsule or sublingual preparation. No formulation or FDA approval claim is inferred.

September 2026

1. 16. The three care options on the weight-loss page do carry different prices, which an earlier reading could not establish. Walking the tabs: Full Strength All-In-One (Care + Home Delivery) shows “Compounded Semaglutide $250.00”; Micro-Dosing All-In-One shows “Microdosing Semaglutide $185.00”; and Care-Only (Pharmacy Pick-Up) shows a flat $75.00 against each of Zepbound®, Wegovy® Injection, Mounjaro®, Ozempic®, Saxenda®, Contrave®, Foundayo and oral semaglutide alike. One figure repeated across eight different medications is the price of the care, not of any of them, and the medication is bought at a pharmacy separately. None of these figures is recorded as a price here, because the page states no billing period for any of them: it says $250.00, not $250.00 a month. The words month, monthly and supply do not appear on the page, there is no pricing page behind it, and the button beside each figure opens the intake rather than a plan. Naming a period the company has not named would make the claim ours rather than theirs.
2. 17. The three care options on the weight-loss page do carry different prices, which an earlier reading could not establish. Walking the tabs: Full Strength All-In-One (Care + Home Delivery) shows “Compounded Tirzepatide $375.00”; Micro-Dosing All-In-One shows “Microdosing Tirzepatide $285.00”; and Care-Only (Pharmacy Pick-Up) shows a flat $75.00 against each of Zepbound®, Wegovy® Injection, Mounjaro®, Ozempic®, Saxenda®, Contrave®, Foundayo and oral semaglutide alike. One figure repeated across eight different medications is the price of the care, not of any of them, and the medication is bought at a pharmacy separately. None of these figures is recorded as a price here, because the page states no billing period for any of them: it says $375.00, not $375.00 a month. The words month, monthly and supply do not appear on the page, there is no pricing page behind it, and the button beside each figure opens the intake rather than a plan. Naming a period the company has not named would make the claim ours rather than theirs.

September 2026

1. 18. Weight-loss page has three care-option tabs — 'Full Strength All-In-One (Care + Home Delivery)', 'Micro-Dosing All-In-One (Care + Home Delivery)', 'Care-Only (Pharmacy Pick-Up)' — but clicking between them with --click kept rendering the same $250/$375 figures, so tier-specific pricing could not be distinguished; recorded prices are whichever tab renders by default. Separately, the site's own comparison table lists a flat $39.99 'Visit Fee' (vs. '$80-$250' for 'Other Telemedicine'), and it is unstated whether that visit fee is bundled into or additional to the $250/$375 GLP-1 prices — the 'Care + Home Delivery' label suggests bundled, but this is not explicit, so it was not treated as a separate membership charge. 'State Coverage' is a javascript:void(0) modal link rather than a real page, so served states could not be confirmed. No cancellation/refund clause was found on the weight-loss terms page checked.